Document is current

Article History

Received: 20 December 2024

Accepted: 25 December 2024

First Online: 7 February 2025

Declarations

:

: CS reports Advisory Board from IDRX  and NewBay; Advisory Board—Speaker—Grant from Deciphera and Blueprint and Speaker from Pharmamar and Roche. MA reports Speaker—Grant from Lilly, Astrazeneca and Roche and Grant from Takeda. NH Advisory Board—Speaker—Grant—Other from PharmaMar  and Deciphera; Speaker from Asofarma and Other from Immunome, INBRX, COGENT, LIXTE, Synox, Abbisko, Lilly, Boehringer and Cebiotex. MASG reports Advisory Board—Speaker—Grant fromRoche Farma; Speaker—Grant from Pzifer; Grant from Astra Zeneca and PharmaMar and Speaker from Deciphera. JMT reports Advisory Board—Other from Pharmamar, GSK and Boehringer; Advisory Board—Speaker from Eisai and Deciphera; Speaker from Roche and Merck and Other from MSD. JMG, RSM, APR, AMD and ICG have nothing to disclose.

: The current study has been performed inaccordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: For this type of study, no informed consent is required.